
Dr. Vogelzang from the Comprehensive Cancer Centers of Nevada discusses mortalities in cabozantinib trial.

Your AI-Trained Oncology Knowledge Connection!


Dr. Vogelzang from the Comprehensive Cancer Centers of Nevada discusses mortalities in cabozantinib trial.

Dr. Infante from Sarah Cannon Research Institute Talks About BRAF Mutation Testing

American Society of Clinical Oncology 2011 Annual Meeting Picture Slideshow Day Four

Dr. Wolchok from Memorial Sloan-Kettering Cancer Center Describes the Immunotherapy Ipilimumab

Dr. Kris From Memorial Sloan-Kettering Cancer Center on the Use of Genetic Testing in Lung Cancer

Dr. Katherine Virgo from the American Cancer Society Discusses Survivorship Care Training & Policies

Dr. Axel Hoos from Bristol Myers-Squib on the Patients That Respond to Ipilimumab

Dr. Paul Chapman from Memorial Sloan-Kettering Cancer Center Describes the Side Effects of Vemurafenib

Apostolia M. Tsimberidou, MD, PhD, from MD Anderson Cancer Center discusses improving cancer care.

Dr. Cella from Northwestern University Feinberg School of Medicine on Patient Assessment Reference Scores

Dr. Heikki Joensuu from the Helsinki University Central Hospital Summarizes the Imatinib for High-Risk high-risk gastrointestinal stromal tumors (GIST) Trial

Tim Turnham the Executive Director of the Melanoma Research Foundation Discusses Melanoma Treatment Advances

ASCO 2011, June 3-7, 2011 McCormick Place, Chicago, IL

Donna Berry on the Distinguished Researcher Award and Her Advice to Researchers

Carlton Brown Describes Key Messages of the ONS Congress

Keynote Presenter Cancer Survivor Charlie Lustman Lives to Tell His Story

Susan Moore Oncology Nurse Practitioner/Consultant, MCG Oncology on Adapting a Practice for Use of Oral Oncolytics

Elizabeth Blasiak on the Significance of the ONS Congress



In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.

Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC

Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom on Trends in Surgical Training

Daniel A. Osman, MD, Founder and Course Director of the Miami Breast Cancer Conference Discusses Methods for Detecting Malignant Conditions in Breast Cancer
